Recruiting NA Ectropion

New treatment option for Ectropion

Official title Steri-Strip Tape Use in Unilateral Ectropion Surgery

ClinicalTrials.gov ID: NCT06935227

What this study is testing

What it's testing
Currently, the incidence of involutional and chronic eyelid disorders, such as ectropion, has been increasing, as human life expectancy has risen worldwide (more than 600 million people are aged ≥ 60 years). Ectropion is a common eyelid malposition that causes visual morbidity.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Patients aged 18 years or older who are scheduled to undergo unilateral ectropion surgery.

You likely can't join if

  • Underlying conditions associated with skin hyperlaxity, such as cutis laxa and Ehlers-Danlos syndrome.
  • Skin diseases that predispose to cicatricial ectropion, such as ichthyosis, scleroderma, and psoriasis.
  • Paralytic ectropion.
  • Current use of oral isotretinoin.

The study team makes the final eligibility decision.

Where it's taking place

  • Bogotá, Colombia

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Bogotá, Colombia. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.